Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2013 | 8 | 6 | 742-748
Tytuł artykułu

Thyroid dysfunction and cardiovascular risk factors in Bulgarian adults

Treść / Zawartość
Warianty tytułu
Języki publikacji
The aim of this study was to determine the prevalence of thyroid dysfunction and its association with cardiovascular risk factors in an adult Bulgarian population. 2402 subjects were studied, 1347 female, 20–94y (median: 48.0y) and 1055 male, 20–91y (median: 45.5y). Body weight, height, waist circumference, arterial blood pressure, TSH, FT4 and lipids were measured. Known hypothyroidism was reported by 53 subjects (2.2%) and hyperthyroidism by 20 (0.8%). New hypothyroidism was found in 98 (4.1%), [subclinical (3.2%), overt (0.9%)]. New hyperthyroidism was found in 68 (2.9%), [subclinical (2.5%), overt (0.4%)]. New diagnosis of hypothyroidism and hyperthyroidism was entered in 84% and 87% in male subjects and 60% and 65% in the females respectively. Arterial hypertension was present in 40% of the women and in 47% of the men (p<0.001) and was more prevalent in hypothyroidism. Abdominal obesity and dyslipidemia were more prevalent in males and hypothyroid subjects. Arterial hypertension depended on age, gender and lipid status but not on thyroid function. CHD history depended on thyroid function and age. Conclusion: Most cases of thyroid dysfunction were undiagnosed, especially in the males. CV risk factors were more prevalent in the males with thyroid dysfunction a major determinant of CHD, but not hypertension.

Opis fizyczny
  • Clinical Center of Endocrinology, Medical University of Sofia, Sofia, Bulgaria,
  • Clinical Center of Endocrinology, Medical University of Sofia, Sofia, Bulgaria
  • Clinical Center of Endocrinology, Medical University of Sofia, Sofia, Bulgaria
  • Clinical Center of Endocrinology, Medical University of Sofia, Sofia, Bulgaria
  • Clinical Center of Endocrinology, Medical University of Sofia, Sofia, Bulgaria
  • Clinical Center of Endocrinology, Medical University of Sofia, Sofia, Bulgaria
  • National Center for Medical Information, Sofia, Bulgaria
  • Clinical Center of Endocrinology, Medical University of Sofia, Sofia, Bulgaria
  • [1] Flynn R., Macdonald T.M., Morris A.D., Jung R.T., Leese G.P. The Thyroid Epidemiology, Audit, and Research Study: Thyroid Dysfunction in the General Population, J Clin Endocrinol Metab., 2004, 89, 3879–3884[Crossref]
  • [2] Gagnon F., Langlois M.F., Michaud I., Gingras S., Duchesne J.F., Levesque B. Spatio-temporal distribution of hypothyroidism in Quebec, Chronic Dis Can., 2006, 27, 1–8
  • [3] Mayer O. Jr., Simon J., Hrbkova J., Pikner R., Topolcan O. Epidemiological study of hypothyroidism as cardiovascular risk in population, Cas Lek Cesk., 2005, 144, 459–464
  • [4] Canaris G.J., Manowitz N.R., Mayor G.M., Ridgway E.C. The Colorado thyroid disease prevalence study, Arch Intern Med., 2000, 160, 526–534[Crossref]
  • [5] Rodondi N., Aujesky D., Vittinghoff E, Cornuz J., Bauer D.C., Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis, Am J Med., 2006, 119, 541–551[Crossref]
  • [6] Remmel K.S., Wanahita A., Moore K., Gruenthal M. Acute ischemic stroke and hypothyroidism, J Ky Med Assoc., 2006, 104, 191–193
  • [7] National Statistical Institute. 2006, at
  • [8] O’Leary P., Feddema P., Michelangeli V. et al. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study, Clinical Endocrinology, 2006, 64, 97–104[Crossref]
  • [9] Flatau E., Trougoubo F., Kaufman N., Reichman N., Luboshitzky R., Prevalence of hypothyroidism and diabetes mellitus in elderly kibbutz members, European Journal of Epidemiology, 2000, 16, 43–46[Crossref]
  • [10] Empson M., Flood V., Ma G., Eastman C.J., Mitchell P. Prevalence of thyroid disease in an older Australian population. Intern Med J., 2007, 37, 448–455[Crossref]
  • [11] Laurberg P., Pedersen K.M., Hreidarsson A., Sigfusson N., Iversen E., Knudsen P.R. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark, J Clin Endocrinol Metab., 1998, 83, 765–769[Crossref]
  • [12] Laurberg P., Bülow Pedersen I., Pedersen K.M., Vestergaard H. Low incidence rate of overt hypothyroidism compared with hyperthyroidism in an area with moderately low iodine intake, Thyroid, 1999, 9, 33–38[Crossref]
  • [13] Ivanova L.B., Ivanova R.B., Kovatcheva R., Lozanov B.S. Urinary iodine excretion in pregnant women after the introduction of universal salt iodization in Bulgaria, Endocrinologya., 2013, 18, 5–11
  • [14] Völzke H., Lüdemann J., Robinson D.M. et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area, Thyroid. 2003, 13, 803–810[Crossref]
  • [15] Knudsen N., Jorgensen T., Rasmussen S., Christiansen E., Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency, Clin Endocrinol. (Oxf), 1999, 51, 361–367[Crossref]
  • [16] Meier C., Staub J.J., Roth C.B. et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study), J Clin Endocrinol Metab., 2001, 86, 4860–4866[Crossref]
  • [17] Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study, BMJ., 1995, 310, 1099–1104[Crossref]
  • [18] Mariotti S., Cambuli V.M. Cardiovascular risk in elderly hypothyroid patients, Thyroid, 2007, 17, 1067–1073[Crossref][WoS]
  • [19] Volzke H., Schwahn C., Wallaschofski H., Dorr M. Review: The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? J Clin Endocrinol Metab., 2007, 92, 2421–2429[Crossref][WoS]
  • [20] Cappola A.R., Fried L.P., Arnold A.M., Danese M.D., Kuller L.H., Burke G.L. et al. Thyroid status, cardiovascular risk, and mortality in older adults, JAMA, 2006, 295, 1033–1041[Crossref]
  • [21] Razvi S., Weaver J.U., Vanderpump M.P., Pearce S.H. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab., 2010, 95, 1734–1740[Crossref]
  • [22] Singh S., Duggal J., Molnar J., Maldonado F., Barsano C.P., Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis, Int J Cardiol, 2008, 125, 41–48[Crossref]
  • [23] Ochs N., Reto A., Bauer D., Nanchen D., Gussecloo J., Cornuz J., Rodondi N. Metaanalysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality, Ann Intern Med., 2008, 148, 832–845[Crossref]
  • [24] Gussekloo J., van Exel E., de Craen AJ., Meinders A.E., Frolich M., Westendorp R.G. Thyroid status, disability and cognitive function, and survival in old age, JAMA., 2004, 292, 2591–2599[Crossref]
  • [25] Hyland K.A., Arnold A.M., Lee J.S., Cappola A.R. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. J Clin Endocrinol Metab., 2013, 98, 533–540[Crossref]
  • [26] Ceresini G., Ceda G.P., Lauretani F., Maggio M., Usberti E., Marina M. et al., Thyroid Status and 6-Year Mortality in Elderly People Living in a Mildly Iodine-Deficient Area: The Aging in the Chianti Area Study. J Am Geriatr Soc., 2013, doi: 10.1111/ jgs.12267 [WoS]
  • [27] Boucai L., Hollowell J.G., Surks M.I. An approach for development of age-, gender-, and ethnicityspecific thyrotropin reference limits. Thyroid., 2011, 21, 5–11[WoS][Crossref]
  • [28] Obuobie K., Smith J., Evans L.M., John R., Davies J.S., Lazarus J.H. Increased central arterial stiffness in hypothyroidism, J Clin Endocrinol Metab., 2002, 87, 4662–4666[Crossref]
  • [29] Saltiki K., Voidonikola P., Stamatelopoulos K., Mantzou E., Papamichael C., Alevizaki M. Association of thyroid function with arterial pressure in normotensive and hypertensive euthyroid individuals: A cross-sectional study, Thyroid Res., 2008, 1, 3[Crossref]
  • [30] Gumieniak O., Perlstein T.S., Hopkins P.N. et al. Thyroid function and blood pressure homeostasis in euthyroid subjects, J Clin Endocrinol Metab., 2004, 89, 3455–3461[Crossref]
  • [31] Verma A., Jayaraman M., Kumar H.K., Modi K.D. Hypothyroidism and obesity. Cause or effect? Saudi Med J., 2008, 29, 1135–1138
  • [32] Fox C.S., Pencina M.J., D’Agostino R.B. et al. Relations of thyroid function to body weight: crosssectional and longitudinal observations in a community-based sample, Arch Intern Med., 2008, 168, 587–592[Crossref]
  • [33] Galofré J.C., Pujante P., Abreu C. et al. Relationship between Thyroid-Stimulating Hormone and Insulin in Euthyroid Obese Men., Ann Nutr Metab., 2008, 53, 188–194[WoS][Crossref]
  • [34] Longhi S, Radetti G. Thyroid function and obesity. J Clin Res Pediatr Endocrinol., 2013, 5,Suppl 1, 40–44
  • [35] Duntas L.H., Biondi B. The Interconnections Between Obesity, Thyroid Function, and Autoimmunity: The Multifold Role of Leptin. Thyroid., 2013, 23, 646–653[Crossref][WoS]
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.